HIV-1 inhibitor-45

• CAT Number: I043310
• CAS Number: 2677762-43-3
• Molecular Formula: C23H24N4O8S
• Molecular Weight: 516.52
• Purity: ≥95%
• Synonyms: 4-(4-aminophenyl)sulfonyl-N-(furan-2-ylmethyl)-1-(3,4,5-trihydroxybenzoyl)piperazine-2-carboxamide
• InChI: InChI=1S/C23H24N4O8S/c24-15-3-5-17(6-4-15)36(33,34)26-7-8-27(23(32)14-10-19(28)21(30)20(29)11-14)18(13-26)22(31)25-12-16-2-1-9-35-16/h1-6,9-11,18,28-30H,7-8,12-13,24H2,(H,25,31)
• InChIKey: RBSXWZYRKATMTP-UHFFFAOYSA-N
• SMILES: C1CN(C(CN1S(=O)(=O)C2=CC=C(C=C2)N)C(=O)NCC3=CC=CO3)C(=O)C4=CC(=C(C(=C4)O)O)O

HIV-1 inhibitor-45（Cat No.:I043310）is a synthetic compound being developed as a potential therapeutic agent for inhibiting the replication of the human immunodeficiency virus type 1 (HIV-1). This inhibitor works by targeting specific enzymes or proteins critical to the HIV replication cycle, such as reverse transcriptase, integrase, or protease, preventing the virus from effectively infecting host cells and spreading. HIV-1 inhibitor-45 shows promise in preclinical studies as part of combination therapies for managing HIV infection. It offers a potential addition to existing antiretroviral treatments, helping to improve treatment outcomes for individuals living with HIV.